4 Results for "

β-catenin-IN-6

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "β-catenin-IN-6" in MCE Product Catalog:

Cat. No.: HY-10834
CAS No.: 1039731-99-1
Purity:  98.65%
Target:  

β-catenin

Research Areas:  

Cancer

β-catenin-IN-6 is a β-catenin inhibitor, targeting to canonical Wingless-related integration site signaling pathway. β-catenin-IN-6 inhibits human colorectal cancer cells proliferation, as well as in a β-catenin/RK3E mouse model .
loading...
    loading...
Cat. No.: HY-172920
Wnt/β-catenin-IN-6 is an orally active Wnt/β-catenin pathway inhibitor. Wnt/β-catenin-IN-6 blocks the AKT/GSK-3β/β-catenin signaling pathway, leading to reduced expression of Wnt target genes (c-Myc, c-Jun). Wnt/β-catenin-IN-6 reduces COX2 expression and IL-8 levels, highlighting its dual anti-inflammatory and antitumor effects. Wnt/β-catenin-IN-6 can induce apoptosis. Wnt/β-catenin-IN-6 serves as a tool for non-small cell lung cancer (NSCLC) research .
loading...
    loading...
Cat. No.: HY-10834R
CAS No.: 1039731-99-1
Research Areas:  

Cancer

β-catenin-IN-6 (Standard) is the analytical standard of β-catenin-IN-6 (HY-10834). This product is intended for research and analytical applications. β-catenin-IN-6 is a β-catenin inhibitor, targeting to canonical Wingless-related integration site signaling pathway. β-catenin-IN-6 inhibits human colorectal cancer cells proliferation, as well as in a β-catenin/RK3E mouse model .
loading...
    loading...
Cat. No.: HY-160493
CAS No.: 1219439-82-3
Target:  

Wnt β-catenin

Research Areas:  

Cancer

PTK7/β-catenin-IN-6 (Compound 03653) is an inhibitor for PTK7/β-catenin interaction, which inhibits the Wnt signaling pathway, and exhibits an anticancer activity against colorectal cancer (CRC) .
loading...
    loading...